Medtronic, Olympus Corporation and Johnson & Johnson Services, Inc. are Dominating the Global Electrosurgery Equipment Market in 2018

Global Electrosurgery Equipment Market is expected to grow at a substantial CAGR of 5.2% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-electrosurgery-equipment-market

The electrosurgery equipment market is a highly fragmented market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to increasing number of surgeries, growing number of minimally invasive surgeries; rising geriatric population coupled with increasing number of chronic diseases and cost effective method as compared to other surgical techniques.

The market has witness developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand. For instance, in August 2017, Ethicon launched PROXISURE, an advanced laparoscopic suturing device which is designed for improving precision in minimally-invasive surgeries. This helped in the expansion of the product portfolio of the company.

Medtronic dominated the electrosurgery equipment market. The other key players existing in the market includes Olympus Corporation and Johnson & Johnson Services, Inc. The other key players existing in the market includes B. Braun Melsungen AG, Boston Scientific Corporation, Kirwan Surgical Products, LLC., Symmetry Surgical, Smith & Nephew, ATMOS MedizinTechnik GmbH & Co. KG, Parkell, Inc., BOWA-electronic GmbH & Co. KG, KLS Martin Group, Applied Medical Resources Corporation, Utah Medical Products, Inc., XCELLANCE Medical Technologies, PRIMA MEDICAL GROUP, Stryker, Tecno Instruments, Electro Surgical Instrument Company, International Group Medical Technology and Electronics GmbH, among others.

Medtronic:

Medtronic headquartered in Dublin, Ireland was founded in 1949. The company is engaged in developing and manufacturing a wide range of products and therapies which emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. The company has four business segments namely, cardiac and vascular group, minimally invasive therapies group, restorative therapies group, diabetes group.

  • In November 2018, Medtronic (Canada) a subsidiary of Medtronic plc announced that it has received a license from the Health Canada for Visualase MRI Guided Laser Ablation System. This Visualase system offers advanced MRI guided laser ablation technology for the use in the cranial neurosurgery procedures. This would also help the company to expand the product in Canada. This introduction of laser technology will benefit the people who battle with brain tumours. By this launch the physicians will have more options to reduce the need of invasive surgery.

It has its global networks through direct sales representatives and distributors in the Australia and New Zealand, Asia Pacific, Eastern Europe, Greater China, Japan, Korea, Latin America, Middle East, Africa, Central Asia and Turkey, South Asia, Southeast Asia, United States of America, Western Europe and Canada. The company has various subsidiaries such as Covidien (Irish), Corventis,Inc. (U.S.), TyRx Pharma Inc. (U.S.), ATS Medical (U.S.), Given Imaging (Israel), United States Surgical Corporation (U.S.) and others.

Olympus Corporation:

Olympus Corporation headquartered in Tokyo, Japan was founded in 1919. The company is engaged in the manufacturing and sales of the precision machineries and instruments. The company mainly manages their operations through the four main operating segments such as medical, scientific solutions, imaging and others.

  • In May 2019, Olympus Corporation launched ESG-150 Electrosurgery Generator at the Digestive Disease Week 2019. This new ESG-150 helps in improving both ease of use and patient safety. This would help in expanding the product portfolio of the company.

It has its global networks through direct sales representatives and distributors in Americas, Asia Pacific, Europe, the Middle East and Africa. It operates through its subsidiaries such as KeyMed (U.K.), Gyrus ACMI, Inc (U.S.), Olympus Corporation of the Americas (U.S.), Olympus New Zealand Limited (New Zealand)), Olympus Korea Co., Ltd. (Korea) among others.

Johnson & Johnson Services, Inc.:

Johnson & Johnson Services, Inc. is headquartered in New Jersey, U.S. and founded in 1886. The company is engaged in the research and development, manufacturing and sales of a wide range of products in the health care field. The company operates through different business segments which include pharmaceutical, medical devices and consumer. The product related to the electrosurgery equipment market falls in the medical devices segment.

  • In November 2017, Johnson & Johnson Services, Inc. opened a new Ethicon factory at Suzhou Industrial Park in China. This expansion will help the company to introduce open surgical equipment and minimally invasive surgical equipment technology in China. This expansion will transform the chain of China‘s medical equipment industry and contribute to the Chinese medical and healthcare industry.

The company has wide geographical presence in Europe, Western Hemisphere, Asia-Pacific, Africa and the U.S. It operates through its subsidiaries such as Janssen Global Services, LLC (Belgium), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), Janssen Global Services, LLC (Belgium) and others.